Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Diagnostically challenging human papillomavirus-associated primary squamous cell carcinoma of the rectum with metastasis in both ovaries: a case report

Abstract

Introduction

Squamous cell carcinomas of the rectum are extremely rare and their pathogenesis is still under debate. Their proper diagnosis and treatment may thus be challenging.

Case presentation

A 52-year-old Caucasian woman was transferred to our department with a history of pelvic pain. Colonoscopy revealed a small tumorous lesion of the upper rectum and an endoscopic biopsy showed infiltration of the rectal mucosa by a squamous cell carcinoma. Afterward, tumorous lesions were found on imaging in both her ovaries. A laparoscopy with adnexectomy and anal mapping was performed and revealed tumor masses of squamous cell carcinoma in both ovaries. Based on the large size of the ovarian tumors and the concurrence of extensive, partly ciliated, macrocystic epithelium in one of the ovaries, a diagnosis of ovarian squamous cell carcinoma arising from a mature teratoma was rendered. However, human papillomavirus genotyping analyses were positive for human papillomavirus-16 in both the rectal tumor and ovarian tumors leading to a final diagnosis of a human papillomavirus-associated rectal squamous cell carcinoma metastatic to both ovaries. Neoadjuvant chemoradiation therapy of her rectum, total mesorectal excision, and hysterectomy were performed followed by adjuvant chemotherapy.

Conclusion

Colorectal squamous cell carcinoma is a rare disease. In cases of colorectal squamous cell carcinoma, metastatic disease at any other location has to be excluded. Human papillomavirus genotyping is essential in this context. Discussion of the treatment strategies should be interdisciplinary and include chemoradiation therapy and radical surgery.

Peer Review reports

Introduction

Colorectal squamous cell carcinoma (SCC) as a primary tumor localization is exceedingly rare and represents only 0.1 to 0.25 per 1000 cases of all colorectal cancers [1,2,3,4]. The majority of the cases are actually anal SCC with proximal extension into the rectum. These cases are largely attributed to human papillomavirus (HPV) infections [5]. In contrast, in the higher rectum there is no clear evidence for an association with HPV infections but an association with human immunodeficiency virus (HIV) [5,6,7]. One possible explanation of HPV infection in the higher rectum is circulating HPV deoxiribonucleic acid (DNA) [8]. Anal SCC affects more women than men and typically appears in the sixth decade of life, mostly with pelvic pain and bleeding [4, 9, 10]. Liver and lung are known to be the first metastasized organs, similar to colorectal adenocarcinoma. The ovaries as first afflicted organ is rare, but well described, and should be considered in the diagnostic pathway. Moreover, approximately 4% of women with intestinal cancers have ovarian metastases at some time in the course of their disease and these are misinterpreted as primary ovarian tumors in 3–20% of cases [11].

In the diagnostic work-up of rectal SCC three possibilities have to be considered: (a) a rectal involvement by an anal SCC, (b) an anal SCC-lined rectum fistula, and (c) a metastasis from another primary tumor location [12, 13]. The diagnosis of SCC should include tissue biopsy, endosonographic ultrasound, magnetic resonance imaging (MRI) of the rectum, and computed tomography (CT) scan.

This case shows a rare constellation of a primary SCC in the rectum with metastasis in both ovaries and an association with HPV infection in a HIV-negative patient. Chemoradiation with or without surgery are the main treatment options, depending on tumor localization, patient’s condition, and functional aspects.

Case presentation

A 52-year-old Caucasian woman was referred to our department in November 2016 with a history of pelvic pain for more than 3 months. Previous to our consultation she had consulted with an orthopedic physician and received physical therapy. Her family, social, and environmental histories showed no abnormalities. She did not smoke tobacco and was not addicted to alcohol or any drugs. No prior medication was reported. Weight loss or B symptoms were not recorded (her history is shown as a timeline in Fig. 1). At the first clinical presentation, a blood pressure of 140/90 mmHg and a pulse of 100 beats per minute (bpm) were observed. Her physical and neurological examinations were uneventful. Results of laboratory findings are listed in Table 1.

Fig. 1
figure1

Timeline of patient’s history. MRI magnetic resonance imaging, RCTX radiochemotherapy, TME total mesorectal excision

Table 1 Laboratory results at first clinical visit

After unsuccessful physical therapy and persistent pelvic discomfort, she was sent for an MRI, where a 30 mm tumorous lesion was found in her middle rectum. A proctoscopy showed a tumorous lesion 7–10 cm from the anal verge (Fig. 2a–d, preoperative staging).

Fig. 2
figure2

Preoperative imaging. a Computed tomography scan. b Magnetic resonance imaging axial. c Endoscopy. d Positron emission tomography scan. In computed tomography scan and magnetic resonance imaging only, primary tumor was clearly detected (red arrow). A cystic ovary was described. To exclude foreign metastasis a positron emission tomography scan was performed with an enhancement in both ovaries (yellow arrows)

The histopathological result of a tissue biopsy was HPV-16 associated SCC (Fig. 3a–d); local staging was performed with endoscopic ultrasound and showed a uT3uN1 stage in the middle rectum. Cancer antigen (CA) 19-9 and carcinoembryonic antigen (CEA) levels were initially elevated (CA 19-9, 42 U/ml; CEA, 6.3 ng/ml); CA 125 was not increased (5 U/ml). A HPV screening of her husband was not performed.

Fig. 3
figure3

Squamous cell carcinoma of the middle rectum. a The tumor involves the mucosal surface and focally displays a tubular growth pattern (arrow) resembling the architecture of adjacent crypts of the normal rectum (arrow). This pattern may be interpreted as an in situ lesion with growth of tumor cells along the basement membranes of the colonic crypts (*). b The invasive tumor component in the submucosa is moderately to poorly differentiated. c The tumor expresses p16. d Shows a positive in situ hybridization result when analyzing for high risk human papillomaviruses

There was no evidence of metastasis in a CT scan of her trunk. However, in positron emission tomography (PET)-CT a mild enhancement in both ovaries was observed.

Consequently, a diagnostic laparoscopy, adnexectomy, and anal mapping were performed. Histopathologic analyses of her ovaries revealed double-sided SCCs and in one of her ovaries extensive cystic structures lined by flat cuboidal and ciliated epithelium. Focally, the cystic epithelium was intimately intermingled with the squamous tumor cells and a diagnosis of a mature teratoma with malignant transformation into SCC was rendered (Fig. 4a–d). The anal mapping exhibited a small, barely visible, anal intraepithelial neoplasia (AIN) grade II without any contact with the rectal mucosa and without any evidence of invasion. The immunohistochemical panel was p16 and p53 positive. Based on the pathologist’s reports of the ovaries, the rectal SCC lesion was first interpreted as a metastasis of the malignant ovarian teratoma. Malignant transformation of ovarian teratoma is not that rare (0.17–2%), whereas SCC transformation is common (80%) [14]. Metastasis to the mesorectum of a SCC-transformed teratoma is also reported [15]. However, a two-step approach similar to the treatment of nodal-positive rectal cancer was chosen, that is, preoperative chemoradiation therapy (CRT) of the rectum with 45 Gy and cisplatin, followed by total mesorectal excision (TME) with hysterectomy en bloc and protective loop ileostomy 6 weeks after CRT with a strong endoscopic and radiological response (Fig. 5a–d). On histologic work-up, only a small remainder of SCC was found in her mesorectum and the resection margins were free from disease.

Fig. 4
figure4

Histologic analyses of the ovaries. Both ovaries showed infiltration by poorly differentiated squamous cell carcinoma. a, b In the right ovary there were multiple cystic gland-like structures (arrows) lined by flat to cuboidal or ciliated epithelium. c The glandular epithelium was intimately intermingled with infiltrative clusters of the squamous cell carcinoma (arrow) leading to an initial diagnosis of a teratoma with malignant transformation. dIn situ hybridization for high risk human papillomaviruses, however, was positive in the squamous cell carcinoma cells and negative in the cystic glandular epithelium, strongly arguing against this interpretation of the findings

Fig. 5
figure5

a, b Endoscopy after chemoradiation therapy with a good clinical and imaging (magnetic resonance imaging) response. On the assumption of a malignant transformed teratoma of the ovary an open total mesorectal excision and hysterectomy en bloc was performed as operative strategy (c) and (d)

Her postoperative course was uneventful. She underwent adjuvant chemotherapy with cisplatin and vinorelbin. The closure of loop ileostomy was performed after systemic therapy. The follow-up was similar to that for colorectal cancer with clinical examination including the monitoring of CA 19-9 and CEA levels every 3 months in the first year. After 12 months a colonoscopy, CT scan, PET scan, and MRI were performed. Annual pelvic MRI, CT scan, and PET scan were used for follow-up with a disease-free survival of 36 months up to now (11/2016–10/2019). Quality of life and function after TME are adequate.

The course of treatment was similar to rectal cancer. The neoadjuvant CRT and adjuvant chemotherapy type was similar to that for SCC with 45 Gy and cisplatin as a combined strategy before the operation, and four cycles of cisplatin and vinorelbin after the operation procedure.

Discussion

This case shows a rare constellation of a HPV-positive rectal SCC with metastasis in both ovaries in a HIV-negative patient. While there is a clear association of anal SCC with the most common subclasses of high risk HPVs, including types 16, 18, 31, and 33, a correlation to rectal SCC has not been clearly established yet [16, 17]. One possible explanation for HPV-associated SCC in the rectum is circulating HPV DNA as discussed by Ambrosio et al. [8]. An alternative pathogenetic pathway may be a misplacement of HPV-infected neoplastic epithelial cells from the anal canal with subsequent implantation of these tumor cells into the rectal mucosa.

Primary SCC of the rectum is rare with an incidence rate of 0.1–0.25 per 1000 cases of colorectal cancers [2, 4,5,6]. These tumors appear more often in women than in men (66% versus 34%) and mostly in the fifth and sixth decades of life; the mean age is 57, the published age range is 39–93 [18].

Symptoms of rectal SCC are similar to those of adenocarcinoma with abdominal or pelvic pain, anal bleeding, changes in bowel habits. and weight loss.

The pathophysiology of rectal SCC is controversial. Chronic irritation after radiation, gastrointestinal infections with Entamoeba histolytica, and schistosomiasis are described as reasons for squamous metaplasia which may lead to malignant progression [12, 19,20,21]. Pluripotent stem cells in gastrointestinal mucosa are suggested by Ouban et al. as an origin of colorectal SCC [22]. Furthermore, a squamous differentiation of adenoma in cloacogenic polyps was described [23].

Already, in 1979, Williams et al. suggested some criteria that are necessary for the diagnosis of a primary colorectal SCC: no evidence of SCC of any other origin, no extension from the anal squamous epithelium, and absence of squamous-lined fistula [12, 24].

The diagnostic work-up should include a CT scan, pelvic MRI, colonoscopy with tissue biopsy, and endosonography. In cases of rectal SCC a PET-CT scan is recommended.

Metastasis of colorectal malignancies (mostly adenocarcinoma) in the ovaries is rare but well described in the literature and should always be considered in cases of cystic formations on preoperative imaging. In the absence of foreign metastasis and suspicious lesions in ovaries only, an adnexectomy should be performed for diagnostic reasons on the one hand and tumor reduction on the other hand.

In our case, there were tumors in both ovaries and a relatively small tumor of the rectum posing the question of the original primary site of the tumor. All the lesions were positive for HPV-16. The first interpretation was that of a SCC derived from a mature teratoma of the ovaries with metastasis to the rectum, which is well described in the literature. However, an association to HPV is rare and mentioned only once in the literature as yet [25]. Retrospective analyses of all tissue samples including immunohistochemistry and HPV in situ hybridization showed that both the rectal and the ovarian squamous carcinoma cells were positive for p16 and HPV of the high risk group. By contrast, the glandular ovarian epithelial cells were HPV-negative and were reclassified as foci of extensive endosalpingiosis (Fig. 4a–d). Molecular HPV genotyping revealed HPV-16 in all tumorous lesions of our patient (rectum, ovaries, and AIN) and a final diagnosis of an HPV-associated rectal squamous cells carcinoma with double-sided metastasis to the ovaries was rendered.

Surgery is the recommended course of treatment for primary colorectal SCC. In cases of ovarian teratomas with malignant transformation, hysterectomy can improve overall survival and was performed in our case [26]. A preoperative combined CRT can be performed in rectal SCC for improved local disease control. Which surgical strategy is chosen depends on the distance of the tumor to the anal verge; however, it should not differ from colorectal adenocarcinoma.

The follow-up should include a CT scan, pelvic MRI, and colonoscopy. In cases of colorectal adenocarcinoma, a PET-CT scan is not necessary [27]. However, in cases of colorectal SCC a PET-CT scan for primary diagnostics is recommended to rule out a metastasis at another location and is also recommended for follow-up.

Data about the prognosis of primary colorectal SCC are sparse. The overall 5-year survival rate is estimated at 32% with significant variation by stage [24]. An improved outcome is suggested with platinum-based CRT [1, 28].

This case shows a rare constellation with metastasis of rectal SCC in both ovaries. The importance of the guidelines which Williams et al. established is illustrated in this case [12]. Moreover, it shows the importance of the treatment of metastasis in colorectal SCC [12].

The role of adjuvant HPV vaccination is controversial. The data in the literature are insufficient. Some data suggest a decreased recurrence rate after adjuvant vaccination [29, 30]. With the implementation of HPV vaccinations we may observe a decrease in SCC at any location in the future. Furthermore, HPV vaccination should be recommended after HPV-associated diseases [31].

Conclusion

Colorectal SCCs are rare. In such cases, metastatic disease at any other location should necessarily be excluded. A PET scan can be a helpful diagnostic tool and should be recommended. Discussion about therapeutic strategy should be interdisciplinary and include CRT and surgery, especially if the rectum is involved. The importance of the treatment of oligometastatic disease in colorectal cancer is clearly shown in this case.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Abbreviations

AIN:

Anal intraepithelial neoplasia

CA:

Cancer antigen

CEA:

Carcinoembryonic antigen

CRT:

Chemoradiation therapy

CT:

Computed tomography

HPV:

Human papillomavirus

PET:

Positron emission tomography

SCC:

Squamous cell carcinoma

TME:

Total mesorectal excision

References

  1. 1.

    Crissman JD. Adenosquamous and squamous cell carcinoma of the colon. Am J Surg Pathol. 1978;2(1):47–54.

  2. 2.

    Juturi JV, Francis B, Koontz PW, Wilkes JD. Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature. Dis Colon Rectum. 1999;42(1):102–9.

  3. 3.

    Kiyani A, Coyle WJ, Bao F. A rare case of primary rectal squamous cell carcinoma diagnosed by endoscopic ultrasound. J Gastrointest Oncol. 2017;8(4):E56–9.

  4. 4.

    Nahas CSR, Shia J, Joseph R, et al. Squamous-cell carcinoma of the rectum: a rare but curable tumor. Dis Colon Rectum. 2007;50(9):1393–400.

  5. 5.

    Matsuda A, Takahashi K, Yamaguchi T, et al. HPV infection in an HIV-positive patient with primary squamous cell carcinoma of rectum. Int J Clin Oncol. 2009;14(6):551–4.

  6. 6.

    Frizelle FA, Hobday KS, Batts KP, Nelson H. Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathologic study. Dis Colon Rectum. 2001;44(3):341–6.

  7. 7.

    Konieczny N, Schwarze-Zander C, Hausen A, et al. HPV-assoziiertes Plattenepithelkarzinom des Rektums bei einer HIV-positiven Patientin--eine seltene Differenzialdiagnose. Zentralblatt fur Chirurgie. 2013;138(Suppl 2):e131–3.

  8. 8.

    Ambrosio MR, Vernillo R, de Carolis S, et al. Putative role of circulating human papillomavirus DNA in the development of primary squamous cell carcinoma of the middle rectum: a case report. Front Oncol. 2019;9:93.

  9. 9.

    Prener A, Nielsen K. Primary squamous cell carcinoma of the rectum in Denmark. APMIS. 1988;96(9):839–44.

  10. 10.

    Vezeridis MP, Herrera LO, Lopez GE, et al. Squamous-cell carcinoma of the colon and rectum. Dis Colon Rectum. 1983;26(3):188–91.

  11. 11.

    Scully RE, Young RH, Clement PB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament. Washington: Armed Forces Institute of Pathology; 1998.

  12. 12.

    Williams GT, Blackshaw AJ, Morson BC. Squamous carcinoma of the colorectum and its genesis. J Pathol. 1979;129(3):139–47.

  13. 13.

    Yeh J, Hastings J, Rao A, Abbas MA. Squamous cell carcinoma of the rectum: a single institution experience. Tech Coloproctol. 2012;16(5):349–54.

  14. 14.

    Comerci JT, Licciardi F, Bergh PA, et al. Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature. Obstet Gynecol. 1994;84(1):22–8.

  15. 15.

    Alatassi H, Moghadamfalahi M. Squamous cell carcinoma of the rectum, primary or metastatic? J Gastrointest Oncol. 2011;2(4):262–4.

  16. 16.

    Nebesio CL, Mirowski GW, Chuang TY. Human papillomavirus: clinical significance and malignant potential. Int J Dermatol. 2001;40(6):373–9.

  17. 17.

    Sotlar K, Köveker G, Aepinus C, et al. Human papillomavirus type 16-associated primary squamous cell carcinoma of the rectum. Gastroenterology. 2001;120(4):988–94.

  18. 18.

    Lafreniere R, Ketcham AS. Primary squamous carcinoma of the rectum. Report of a case and review of the literature. Dis Colon Rectum. 1985;28(12):967–72.

  19. 19.

    Audeau A, Han HW, Johnston MJ, et al. Does human papilloma virus have a role in squamous cell carcinoma of the colon and upper rectum? Eur J Surg Oncol. 2002;28(6):657–60.

  20. 20.

    Pemberton M, Lendrum J. Squamous-cell carcinoma of the caecum following ovarian adenocarcinoma. Br J Surg. 1968;55(4):273–6.

  21. 21.

    Wiener MF, Polayes SH, Yidi R. Squamous carcinoma with schistosomiasis of the colon. Am J Gastroenterol. 1962;37:48–54.

  22. 22.

    Ouban A, Nawab RA, Coppola D. Diagnostic and pathogenetic implications of colorectal carcinomas with multidirectional differentiation: a report of 4 cases. Clin Colorectal Cancer. 2002;1(4):243–8.

  23. 23.

    Jaworski RC, Biankin SA, Baird PJ. Squamous cell carcinoma in situ arising in inflammatory cloacogenic polyps: report of two cases with PCR analysis for HPV DNA. Pathology. 2001;33(3):312–4.

  24. 24.

    Sonia Z, Amira D, Hanene B, et al. Complete pathologic response after chemoradiotherapy in a patient with rectal squamous cell carcinoma: a case report. Cancer Biol Med. 2017;14(4):414–7.

  25. 25.

    Chiang A-J, Chen D-R, Cheng J-T, Chang T-H. Detection of human papillomavirus in squamous cell carcinoma arising from dermoid cysts. Taiwan J Obstet Gynecol. 2015;54(5):559–66.

  26. 26.

    Li C, Zhang Q, Zhang S, et al. Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review. BMC Cancer. 2019;19(1):217.

  27. 27.

    Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF. Leitlinienprogramm Onkologie: S3-Leitlinie Kolorektales Karzinom: Langversion 2.1; 2019. http://www.leitlinienprogramm-onkologie.de/leitlinien/kolorektales-karzinom/ (23.12.2019)

  28. 28.

    Dyson T, Draganov PV. Squamous cell cancer of the rectum. World J Gastroenterol. 2009;15(35):4380–6.

  29. 29.

    Dion GR, Teng S, Boyd LR, et al. Adjuvant human papillomavirus vaccination for secondary prevention: a systematic review. JAMA Otolaryngol Head Neck Surg. 2017;143(6):614–22.

  30. 30.

    Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol. 2013;130(2):264–8.

  31. 31.

    AWMF online. S3-Leitlinie zur Impfprävention HPV-assoziierter Neoplasien; 2013. https://www.hpv-impfleitlinie.de/doc/2013_langfassung_082-002l_Impfpraevention_HPV_assoziierter_Neoplasien_2013-12.pdf (23.12.2019)

Download references

Acknowledgements

Special thanks to Prof. Offner (Institute for Pathology) for the interesting discussions during this work.

Funding

We did not receive any funding.

Author information

All authors read and approved the final manuscript.

Correspondence to P. Tschann.

Ethics declarations

Ethics approval and consent to participate

There is no conflict of interest.

There was no research on human or animal participants.

Consent for publication

Written informed consent was obtained from the patient for the publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tschann, P., Lechner, D., Feurstein, B. et al. Diagnostically challenging human papillomavirus-associated primary squamous cell carcinoma of the rectum with metastasis in both ovaries: a case report. J Med Case Reports 14, 30 (2020). https://doi.org/10.1186/s13256-020-2348-5

Download citation

Keywords

  • Squamous cell carcinoma
  • Human papillomavirus
  • Rectum
  • Metastasis
  • Ovary